Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Pan American Silver released its quarterly results after the bell, delivering a blend of record revenue and strong ea...
EU officials press Washington to honor its trade commitments after a Supreme Court ruling sparks tariff chaos. The bl...
The FTC signals a softer regulatory stance under a Trump administration, even as a new study shows a fifth of America...
Ethereum co-founder Vitalik Buterin floated a model where AI assists with wallet decisions but humans approve large t...
FedEx faces a choppy 2026 as it leans on automation and global expansion. Analysts offer a wide range of targets for ...
Zcash slid roughly 15% in 48 hours, pushing toward $230 as a classic reversal pattern took hold and market sentiment ...
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...
Discover how Hudson Pacific Properties is shaping its 2026 path after Q1 results. This guide breaks down earnings sig...
A leading Wall Street chartist warns that US tech concentration has reached levels not seen since the dot-com bubble,...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
Applovin rallied today as traders weighed an upbeat analyst note against a quiet news cycle. This piece breaks down t...